EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Correlation of polygenic risk score and clinical phenotype in patients with genetic generalized epilepsy

Sophie von Brauchitsch iD, Nils Hartung, Robin A Karge iD, Bobby Koeleman, Samuel F Berkovic iD, Danielle M Andrade, Francesca Bisulli iD, Antonio Gambardella iD, Renzo Guerrini, Ingrid E Scheffer, Ingo Helbig iD, Wolfram S Kunz und 16 weitere

Epilepsia · 2026-11 · 67 (11) · 6005-6014

DOI: 10.1002/epi.70444 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 22.08.2026. Verfasst von Sophie von Brauchitsch und 27 weiteren Autor:innen. Beteiligte Einrichtung: Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, University Medical Center and Goethe University Frankfurt, Frankfurt, Germany. Hauptthemen laut MEDLINE: Epilepsy, Generalized, Multifactorial Inheritance. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, NHGRI NIH HHS, Detlev-Wrobel-Fonds for Epilepsy Research Frankfurt, Germany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The polygenic risk score (PRS) for individuals with genetic generalized epilepsy (GGE) quantifies the common risk variants in genes identified in genome‐wide association studies. We hypothesized that the phenotype of GGE patients differs based on their GGE PRS.

Methods

We identified participants with highest ( n = 59) versus lowest ( n = 48) PRS from the GGE patients ( n = 2256) recruited through the Epi25 Collaborative for comparison. Detailed clinical data were acquired retrospectively for the 59 high PRS and 48 low PRS individuals with GGE from the Epi25 database and from the contributing centers. For validation, we accessed a larger cohort ( n = 1175) of patients with GGE included in the Epi25 Collaborative.

Results

This study found no difference in phenotypic features of patients between the high‐PRS GGE and low‐PRS GGE subgroups, including age at onset, family history, and specific GGE syndrome. However, more patients from the lowest compared to the highest PRS subgroup were pharmacoresistant (31.7% vs. 8.9%, p = .01). On validation in a larger cohort, the PRS did not differ in the group of pharmacoresistant compared to nonpharmacoresistant patients. Significance No meaningful association between PRS and age at onset, history of febrile seizures, pre‐/perinatal complications, epilepsy syndromes, seizure types, co‐occurrence of functional/dissociative (nonepileptic) seizures, psychiatric comorbidities, electroencephalographic/magnetic resonance imaging findings, or drug response could be demonstrated in this study of people with GGE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epilepsy, GeneralizedMultifactorial InheritanceHumansGenetic Risk ScoreFemalePhenotypeMaleAdultYoung AdultRetrospective StudiesGenome-Wide Association StudyAdolescentGenetic Predisposition to DiseaseDrug Resistant EpilepsyMiddle Aged

Stichwörter der Autor:innen

EEGcomplex inheritanceepilepsy geneticsgenotype–phenotype correlationheritabilitypharmacoresponse

Autor:innen und Institutionen

  • Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, University Medical Center and Goethe University Frankfurt, Frankfurt, Germany.
  • Center for Personalized Translational Epilepsy Research, Goethe University Frankfurt, Frankfurt, Germany.
  • Section of Epileptology, Department of Neurology, RWTH Aachen University, Aachen, Germany.
  • Department of Medical Genetics, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Epilepsy Research Centre, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.
  • Adult Genetic Epilepsy Program, Division of Neurology, Krembil Brain Institute, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Sophie von Brauchitsch, Robin A Karge, Samuel F Berkovic, Francesca Bisulli, Antonio Gambardella, Ingo Helbig, Christian Boßelmann, Sanjay M Sisodiya, Pasquale Striano, Lynnette Sadleir, Yvonne Weber, Dennis Lal, Stefan Wolking, Felix Rosenow, Karl Martin Klein

Förderung

  • Deutsche Forschungsgemeinschaft
  • NHGRI NIH HHS
  • Detlev-Wrobel-Fonds for Epilepsy Research Frankfurt, Germany
  • Health Research Council of New Zealand
  • Wales Gene Park
  • Bundesministerium für Forschung und Technologie
  • HCRW_
  • LOEWE Program of the State of Hesse, Germany

Zitieren

APA

von Brauchitsch, S., Hartung, N., Karge, R. A., Koeleman, B., Berkovic, S. F., Andrade, D. M., Bisulli, F., Gambardella, A., Guerrini, R., Scheffer, I. E., Helbig, I., Kunz, W. S., Lerche, H., Muhle, H., Boßelmann, C., Papacostas, S. S., Rees, M. I., Sisodiya, S. M., Striano, P., …, & Epi25 Collaborative (2026). Correlation of polygenic risk score and clinical phenotype in patients with genetic generalized epilepsy. Epilepsia, 67(11), 6005-6014. https://doi.org/10.1002/epi.70444

Vancouver

von Brauchitsch S, Hartung N, Karge RA, Koeleman B, Berkovic SF, Andrade DM, et al. Correlation of polygenic risk score and clinical phenotype in patients with genetic generalized epilepsy. Epilepsia. 2026;67(11):6005-6014. doi:10.1002/epi.70444

BibTeX
@article{vonBrauchitsch2026,
  author = {von Brauchitsch, Sophie and Hartung, Nils and Karge, Robin A and Koeleman, Bobby and Berkovic, Samuel F and Andrade, Danielle M and Bisulli, Francesca and Gambardella, Antonio and Guerrini, Renzo and Scheffer, Ingrid E and Helbig, Ingo and Kunz, Wolfram S and Lerche, Holger and Muhle, Hiltrud and Boßelmann, Christian and Papacostas, Savvas S and Rees, Mark I and Sisodiya, Sanjay M and Striano, Pasquale and Sadleir, Lynnette and Weber, Yvonne and Lal, Dennis and Leu, Costin and Reif, Philipp S and Wolking, Stefan and Rosenow, Felix and Klein, Karl Martin and Epi25 Collaborative, Epi25 Collaborative},
  title = {Correlation of polygenic risk score and clinical phenotype in patients with genetic generalized epilepsy},
  journal = {Epilepsia},
  year = {2026},
  volume = {67},
  number = {11},
  pages = {6005--6014},
  doi = {10.1002/epi.70444}
}
Kostenlos starten →